EFPIAUS-EU trade conflictUS and EU confirm tariff deal on pharmac...The US and EU have confirmed a trade agreement involving US import tariffs of 15% on prescription medicines. Generics manufacturers will face a maximum tariff of 2.5%. more ➔
MalliaHair growthMallia Aesthetics is about to launch MAL...Germany’s Mallia Aesthetics GmbH has announced the achievement of key regulatory milestones in preparation for the market launch of its sCD83-based hair growth stimulant, MAL-838, later this year. … more ➔
BioMed XMetabolic DisordersBioMed X and Novo Nordisk collaborate to...Novo Nordisk has entered a collaboration with research institute BioMed X in an effort to regain market position lost to leading competitors in diabetes and obesity treatment. The partnership is focused … more ➔
Anocca ABImmunoncologyAnocca raises €38.4m to advance TCR-T le...Swedish immunoncology specialist Anocca AB has raised SEK440m (€38.36m) ahead of enrolling pancreatic cancer patients in a Phase I umbrella trial evaluating the safety of its T-cell receptor-engineered … more ➔
© EdiMembre/MerckAlternative ProteinMerck and mantro enter the foodtech marketThe laboratory division of Merck KGaA has, in partnership with the German company builder Mantro GmbH, established EdiMembre Inc, a Massachusetts-based company set to deploy Merck’s technologies for … more ➔
adobe stock photos - Tomas RaginaPharmaceutical SupplyTrump delays 250% tariffs on non-U.S. ph...U.S. President Donald Trump’s announcement regarding new tariffs on pharmaceutical goods imported into the United States has been delayed. Despite the President’s threat early last week that a tariff … more ➔
NanoCell Therapeutics IncFinancingCPTx and NanoCell Therapeutics secure Eu...German CPTx GmbH, its CDMO Gxstrands, and the US start-up NanoCell Therapeutics have been awarded a Eurostars grant for their QUIET-CAR project, funded through the EU’s Horizon Europe programme and … more ➔
Pilatus BiosciencesCancer ImmunotherapyPilatus Biosciences Enters Clinical Coll...Pilatus Biosciences AG, a Swiss biotechnology company headquartered in Epalinges with operations in the United States and South Korea, has entered into a clinical trial collaboration with Roche AG. As … more ➔
adpbe stock photos - David A Litman CancerBayer announces US$1.3bn oncology deal w...Bayer AG’s Pharmaceuticals division in Berlin has expanded its oncology pipeline through a licensing and collaboration agreement with US-based Kumquat Biosciences Inc., which may yield up to US$1.3bn … more ➔
IO BiotechCancer vaccinationIO Biotech’s cancer jab falls short in P...IO Biotech has published top-line results from its pivotal Phase 3 trial evaluating the therapeutic cancer vaccine IO102-IO103 (Cylembio) in combination with pembrolizumab in patients with advanced melanoma. … more ➔
EFPIA
Mallia
BioMed X
Anocca AB
© EdiMembre/Merck
adobe stock photos - Tomas Ragina
NanoCell Therapeutics Inc
Pilatus Biosciences
adpbe stock photos - David A Litman 
IO Biotech